Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7388 p196
18 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Hope for narcoleptics to regain muscle tone

Narcoleptics can now be treated to reduce the loss of muscle tone that narcolepsy induces.

The new treatment (Xyrem) has as its active substance the sodium salt of gamma hydroxybutyrate (sodium oxybate). Gamma hydroxybutyrate is a CNS depressant with well known abuse potential, so the summary of product characteristics advises evaluating patients for a history of drug abuse and following them closely. The recommended starting dose is 2.25g (4.5ml) twice a day.

The dose should be adjusted up or down in increments of 0.75g per dose up to a maximum of 4.5g twice a day to achieve best effect and tolerability. A minimum of two weeks is recommended between dosage increments.

Xyrem should be taken orally upon getting into bed and again between 2.5 and 4 hours later — the SPC recommends that both doses of Xyrem be made up at the same time (on retiring to bed).


Notice-board p200

Back to Top


©The Pharmaceutical Journal